Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Mar 5:2015:bcr2014208215.
doi: 10.1136/bcr-2014-208215.

Neuropsychiatric systemic lupus erythematosus: a diagnostic challenge

Affiliations
Case Reports

Neuropsychiatric systemic lupus erythematosus: a diagnostic challenge

Andrew Sommerlad et al. BMJ Case Rep. .

Abstract

A 58-year-old woman presented to neuropsychiatric services with increased frequency of confusional episodes and intermittent psychotic symptoms. She had a 19-year history of atypical epileptic seizures and cognitive decline. Detailed review of history and clinical investigations revealed that she had accumulated sufficient features to meet diagnostic criteria for systemic lupus erythematosus (SLE). She had previously had lymphopenia and a malar rash; she had positive antinuclear, anti-Ro (anti-Sjögren's-syndrome-related antigen A) and anti-SM (anti-Smith Antibody) antibodies, and elevated erythrocyte sedimentation rate. The seizures, cognitive impairment and psychosis were attributable to neuropsychiatric SLE. Treatment with immune-modulating therapy, cyclophosphamide, resulted in significant improvement in subjective and objective clinical presentation. Neuropsychiatric SLE should be considered a potential differential diagnosis for patients presenting with seizures, psychotic symptoms or cognitive decline. A detailed clinical evaluation with review of the medical history and appropriate laboratory analyses allows this diagnosis to be made, and appropriate treatment to be initiated.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ainiala H, Loukkola J, Peltola J. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496–500. 10.1212/WNL.57.3.496 - DOI - PubMed
    1. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725 10.1002/art.1780400928 - DOI - PubMed
    1. Esdaile J. Lupus. The disease with a thousand faces [French]. Union Med Can 1991;120:357–8. - PubMed
    1. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L et al. . Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620–5. 10.1136/ard.2004.025528 - DOI - PMC - PubMed
    1. Lau C, Yin G, Mok M. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006;15:715–19. 10.1177/0961203306072311 - DOI - PubMed

Publication types

MeSH terms